What is Isracann Biosciences Inc. (ISCNF)?

Isracann Biosciences Inc. (ISCNF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of ISCNF?

The current price of ISCNF is $0.00. Prices are updated in real time on Stocks360.

What is ISCNF's price-to-earnings (PE) ratio?

ISCNF's trailing twelve-month PE ratio is -0.47, based on current price and earnings per share data available on Stocks360.

What is ISCNF's market capitalization?

ISCNF's market capitalization is $1,760.00, placing it in the small-cap tier.

Isracann Biosciences Inc. (ISCNF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$1.76K

PE (TTM)

-0.47

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.19

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

68.18K

Isracann Biosciences Inc. (ISCNF) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.76K. Trailing PE -0.47. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 8 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-28 · $0.00 2026-10-26 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Isracann Biosciences Inc.

Isracann Biosciences Inc., operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure. Additionally, it ships its products internationally to Germany. The company rebranded to Isracann Biosciences Inc. in October 2019, having previously been known as Atlas Blockchain Group Inc. Founded in 2010, its corporate headquarters are situated in Vancouver, Canada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.47×
P/S (TTM)	0.00×
P/B	7.55×
P/FCF (TTM)	-1.50×
EV / EBITDA	-0.97×
EV / Sales	0.00×
Earnings Yield	-211.75%
Free Cash Flow Yield	-66.46%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.43M
Net Income (TTM)	-$5.59M
Free Cash Flow (TTM)	-$1.74M
Net Debt	-$213.94K
Working Capital	-$570.38K
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	-221.78%
Return on Invested Capital	-0.05%